Chemotherapy drug resistance is a major obstacle in the treatment of cancer. It can result from an increase in levels of cellular drug efflux pumps such as P-glycoprotein (P-gp). Using cellular models, this thesis aimed to investigate resistance in lung cancer cells while developing siRNA and membrane proteomic techniques and to increase our knowledge of the effect of lapatinib, a newly developed targeted therapy, in these resistant cells. Lapatinib, a growth factor receptor tyrosine kinase inhibitor synergised with P-gp substrate cytotoxics in P-gp over-expressing resistant cells. However, lapatinib treatment, at clinically relevant concentrations, also increased levels of the P-gp drug transporter in a dose-responsive manner. Conversely...
We conducted a large-scale functional genetic study to characterize mechanisms of resistance to ALK ...
More than 80% of lung cancer patients die from drug-resistant, metastatic disease. Our focus is to i...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Chemotherapy drug resistance is a major obstacle in the treatment of cancer. It can result from an i...
This thesis sets out to increase our knowledge of mechanisms by which lung cancer cells develop resi...
The PI3K-mTOR pathway is involved in regulating all hallmarks of cancer, and is often dysregulated i...
Lung cancer remains the most common cause of cancer-related deaths globally. The work in this thesis...
This thesis sets out to increase our knowledge of mechanisms by which lung cancer cells develop resi...
Treatment with the taxanes, docetaxel and paclitaxel, can result in the emergence of multi-drug resi...
SummaryWe conducted a large-scale functional genetic study to characterize mechanisms of resistance ...
Introduction: Lung tumors with mutations in epidermal growth factor receptor (EGFR) gene represent a...
Cisplatin is a first line chemotherapeutic agent for lung cancer however, although patients may resp...
ABSTRACT PKC ISOZYMES IN LUNG CANCER DEVELOPMENT AND THERAPY RESISTANCE Mahlet B. Abera Marcelo G. K...
One of the most important pathways in non-small cell lung cancer (NSCLC) is the epidermal growth fac...
がん進展制御研究所Recent advances in molecular biology have led to the identification of new molecular target...
We conducted a large-scale functional genetic study to characterize mechanisms of resistance to ALK ...
More than 80% of lung cancer patients die from drug-resistant, metastatic disease. Our focus is to i...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Chemotherapy drug resistance is a major obstacle in the treatment of cancer. It can result from an i...
This thesis sets out to increase our knowledge of mechanisms by which lung cancer cells develop resi...
The PI3K-mTOR pathway is involved in regulating all hallmarks of cancer, and is often dysregulated i...
Lung cancer remains the most common cause of cancer-related deaths globally. The work in this thesis...
This thesis sets out to increase our knowledge of mechanisms by which lung cancer cells develop resi...
Treatment with the taxanes, docetaxel and paclitaxel, can result in the emergence of multi-drug resi...
SummaryWe conducted a large-scale functional genetic study to characterize mechanisms of resistance ...
Introduction: Lung tumors with mutations in epidermal growth factor receptor (EGFR) gene represent a...
Cisplatin is a first line chemotherapeutic agent for lung cancer however, although patients may resp...
ABSTRACT PKC ISOZYMES IN LUNG CANCER DEVELOPMENT AND THERAPY RESISTANCE Mahlet B. Abera Marcelo G. K...
One of the most important pathways in non-small cell lung cancer (NSCLC) is the epidermal growth fac...
がん進展制御研究所Recent advances in molecular biology have led to the identification of new molecular target...
We conducted a large-scale functional genetic study to characterize mechanisms of resistance to ALK ...
More than 80% of lung cancer patients die from drug-resistant, metastatic disease. Our focus is to i...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...